* ese authors contributed equally to this work PEG10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metalloproteinase-2 and -9 Abstract Purpose: Paternally expressed gene 10 (PEG10) is important for apoptosis resistance in cancer cells; however, the e ect of PEG10 on tumor cell migration remains poorly understood. In this study, we investigated the e ects of PEG10 on proliferation, apoptosis, adhesion and migration in the Burkitt's lymphoma cell line, Raji.
Lymphoma is a malignant, proliferative hematopoietic cell disorder which leads to a variable survival time that ranges from months to decades.
e incidence of Non-Hodgkin's lymphoma (NHL) has been rising continuously for some years and is now the h most common cancer. Burkitt's lymphoma (BL) is a unique neoplasm with the shortest doubling time and highest invasive potential. Its unequalled proliferation rate creates special challenges for diagnosis and treatment. e traditional therapeutic approaches for treatment of BL have been shown to be highly successful; however, recovery of patients with migration or recurrent disease remains very poor. Longterm survival is only 10-20% for migration or recurrent BL [1, 2] .
Paternally expressed gene 10 (PEG10) is a gene from a newly de ned imprinted region located at human chromosome 7q21 [3] . It has an elevated level of expression in the majority of the human hepatocellular carcinoma cells (HCC), and regenerating mouse liver cells [4, 5] . Exogenous expression of PEG10 confers oncogenic activity and transfection of PEG10 siRNAs to hepatoma cells and suppressing its expression results in cancer cell growth inhibition. Overexpression of PEG10 decreases the cell death mediated by SIAH1, a mediator of apoptosis [6] . PEG10 also appears to be important during placental development and during brain development [7] [8] [9] .
Kainz reported elevated expression of PEG10 in cases of high-risk B-cell chronic lymphocytic leukemia (B-CLL), which is de ned by high lipoprotein lipase mRNA expression and long term inhibition of PEG10 leading to induction of apoptosis in B-CLL cells [10] . In our previous research, B-cell acute lymphocytic leukemia (B-ALL) CD23+CD5+B cells the interaction of CCL19/CCR7 and CXCL13/CXCR5 were found to upregulate PEG10 expression, which resulted in enhanced apoptotic resistance in these cells [11] . Other previously reported studies have demonstrated that, in addition to apoptosis, overexpressed levels of CCR7 and CXCR5 on tumor lymphocytes are closely related to cell migration and in ltration [12, 13] . e relationship between elevated expression of PEG10 and the invasion and migration abilities of lymphoma cells remains unclear. We hypothesize that the elevated expression of PEG10 not only enhances apoptotic resistance but also promotes the invasion and migration of lymphoma cells.
e hallmark of tumor cell invasion and migration is excessive degradation of the extracellular matrix. e matrix metalloproteinases (MMPs) are a multigene family of structurally related endopeptidases that are capable of collectively degrading all of the components of the extracellular matrix (ECM) [14] . MMPs have been implicated in many normal and diseaserelated processes including development, arthritis and tumor invasion and migration [15, 16] . Among all of the MMPs, MMP-2 and MMP-9 have been shown to be critical enzymes in cancer cell invasion and migration. Overexpression of MMP-2 and MMP-9 is associated with increased dissemination and in ltration of lymphoma cells [17, 18] .
To investigate whether PEG10 plays a role in the apoptosis, migration and invasion of lymphoma cells, the e ects of PEG10 on proliferation, apoptosis, adhesion and invasion were investigated in Raji cells. PEG10 is shown to enhance apoptotic resistance, proliferation and adherence. e invasion ability of Raji cells could potentially be a ected by PEG10 through regulation of the expression of MMP-2 and MMP-9. Our ndings demonstrate a potential new target for a novel therapeutic approach to treatment of lymphoma.
Materials and Methods
Cell culture and reagents e human BL cell line, Raji, the human hepatoma cell line, BEL-7404, and HEK293T cells (Cell Bank of the Institute of Biochemistry and Cell Biology, SIBS, CAS) were grown in monolayers and cultured in RPMI1640 (Hyclone) or Dulbecco's modi ed Eagle's medium (DMEM) with High Glucose (Hyclone) and supplemented with 10% heat inactivated fetal bovine serum (Hyclone) and maintained at 37°C in 5% CO2.
e open reading frame (ORF) of human PEG10, which is identical to NM_015068, contains 325 amino acids. Fulllength cDNA corresponding to the ORF of PEG10 was isolated from BEL-7404 cells, and then subcloned it into pcDNA3.0 plasmid between Hind III and EcoR I restriction sites. e orientation and correct frame of the recombinant vector pcDNA3.0/PEG10 was con rmed by sequencing.
e MMP-2/-9 monoclonal antibodies used for Western blot analysis were purchased from Biolegend. e secondary antibodies conjugated with peroxidase were purchased from Rockland. Other reagents included Cell Counting Kit-8 (Dojindo), Matrigel and Millicell plates (Millipore), Fibronectin (Chemicon), Oligofectamine and Opti-MEM (Invitrogen) and primers for MMP-9/-2 and GAPDH (Invitrogen). SuperSignal West Pico Trial Kit Detection System (Pierce) was also utilized.
siRNA and transfection
SiRNA oligonucleotides were designed and synthesized as previously reported [19] . e siRNA against PEG10 was named siRNAPEG10, and an unspeci c control siRNA was composed of random sequences.
e sequences of siRNAs were as follows: For the Oligofectamine transfection, 5×105 cells were plated in 12-well plates prior to transfection in accordance with the manufacturer's instructions. Next, the siRNAs were diluted with an appropriate concentration of Opti-MEM I to form complexes. e cells were washed with RPMI1640 to remove serum and supplemented with 10% fetal calf serum 6 h post-transfection. e Raji cells were then transiently transfected with the complexes obtained by Oligofectamine. e HEK293T cells were transiently transfected with pcDNA3.0 and the recombinant vector pcDNA3.0/PEG10 by Lipofectamine 2000. e viability of the cells was tested by removing a portion of cells from the culture plate and counting them with a haemocytometer a er trypan blue staining.
FACS analysis
For detection of apoptosis, cells were seeded on 6-well plates (5×105 cells/well) and transfection were performed as described above. 5-Fluorouracil (5-FU) (100 μg/ml) was then added directly to the medium 24 h a er transfection to induce apoptosis. A er 72 h, cells were collected by trypsinization and washed twice with cold PBS. e cells were then xed in citrate bu er and stained with propidium iodide (PI). e DNA content of the cells was estimated by uorescence-activated cell sorting (FACS) analysis.
Cell proliferation assay
Raji cell suspension (100 μl, 5,000 cells/well) was dispensed in the 96-well plate at 37°C under 5% CO2. e cells were transiently transfected with various concentrations of siRNAs by Oligofectamine. A er incubation for 48 h, CCK-8 solution (10 μl) was added to each well of the plate. e plate was then incubated for 3 h. e absorbance was measured using a PerkinElmer 2030 VICTOR X Multilabel Plate Reader at 450 nm.
Cell adherence assay
Fibronectin (20 mg/L) was pre-incubated in the 96-well plate overnight at 37°C in 5% CO2. Excess liquid was discarded and 100 μl 2% BSA was added to each well. A er 1 h incubation, 100 μl of Raji cell suspension (5,000 cells/well) was dispensed into the 96-well plate. e cells were transiently transfected with various concentrations of siRNAs by Oligofectamine.
A er incubation for 48 h, CCK-8 solution (10 μ) was added to each well of the plate . e plate was then incubated for 3 h . Finally, each plate was washed three times with PBS, aside from the control and one cell counting sample, and the absorbance rate was measured at 450 nm using a PerkinElmer 2030 VIC-TOR X Multilabel Plate Reader.
Real-time quantitative reverse transcription (RT)-PCR assay
e total RNA was extracted from cells using the uick Prep total RNA extraction kit (Pharmacia Biotech) and digested by RNase free DNase at 37°C for 60 min. e DNase was then heat-inactivated at 65°C for 10 min. RNA was reverse transcribed using oligo (dT)18 and Reverse Transcriptase (Life Technologies). e samples were incubated at 42°C for 60 minutes, then heated at 95°C for 5 minutes to inactivate the Reverse Transcriptase. Real-time quantitative PCR was performed with ABI PRISMs 7700 SequenceDetector Systems. A SYBRs Green PCR Core Reagents Kit was used to generate uorescence signals during each PCR cycle. e sequences of the speci c primers were as follows:
e data were expressed as relative mRNA (gene) copies in 25 ng complementary DNA, which was normalized with the expression of a target gene to a housekeeping gene GAPDH. PCR reaction conditions were 2 min at 50°C, 10 min at 94°C, 40 cycles with 15 s at 94°C followed by 30 s at 60°C for amplications.
Western blot assay
e polyclonal antibody to PEG10 was puri ed from sera of rabbits immunized with recombinant PEG10-his tag protein produced in E. coli. Cell extracts were prepared using SDS loading bu er (4% SDS, 1% Triton X-100, 50 mM Tris-HCl, pH 7.4). Proteins were separated by 12% SDS-PAGE and transferred to PVDF membranes. e membranes were blocked with 5% non-fat milk T-TBS (0.1% Tween-20, 100 mM Tris-HCl, 0.9% NaCl) and incubated with antibodies. Goat peroxidase-conjugated a nity puri ed IgG served as the secondary antibody for the SuperSignal West Pico Trial Kit Detection System. Band intensity was measured by densitometry using the uantity One so ware (Bio-Rad, Hercules, CA). GAPDH served as an internal control.
Matrigel in asion assay
Matrigel was thawed at 4°C overnight, and then diluted with serum-free cold RPMI1640. Raji cells were transfected with various concentrations of siRNAs using Oligofectamine. e cells were prepared for further treatment following incubation for 24 h. Brie y, the cell culture inserts (8 μm pore size) were coated with 100 μl Matrigel (2 mg/ml), placed in a 24-well plate, and incubated at 37°C to allow gelling. e gel was gently washed with warmed serum free-RPMI1640. Next, 100 μl of the transfected cell suspension was placed into the upper chamber, and 600 μl of serum free RPMI1640, containing 5 μg/ml bronectin, was placed into the lower chamber of the transwell. e plate was incubated at 37°C for another 24 h. e transwell inserts were removed from the 24-well plates a er incubation. Cells that had not migrated were scraped o with a cotton swab. e inserts were then xed in methanol for 10 min at room temperature and stained with hematoxylin. Cells that had migrated to the lower surface were counted using a light microscope in ve pre-determined elds at a magnication of 200 fold.
Statistical analysis
Experiments were performed in triplicate and repeated at least six times. Data are expressed as mean values ± standard deviation, and statistical signi cance was assessed by one-way ANOVA for independent groups using the SPSS 11.0 program. A value of P<0.05 was considered to indicate a statistically signi cant di erence.
Results

PEG10 plays an important role in apoptosis
A common chemotherapeutic agent, 5-FU is used in vitro as an inducer of apoptosis in cancer cells. In our study, a small dose (100 μg/ml) of 5-FU was used to induce apoptosis in Raji cells. Our results demonstrated that the apoptosis rate of the blank control group was 2.93%, the 5-FU group was 15.47%, and the siRNA PEG10 (40 nM) and unspeci c control siRNA (40 nM) groups were 6.46% and 4.69%, respectively. Inhibition of PEG10 expression alone did not a ect the growth of Raji cells, when compared with the blank control, whereas siRNAPEG10 and the unspeci c control siRNA exhibited an e ect when used along with 5-FU, with apoptosis rates of 30.83% and 16.80%, respectively (Fig 1) . ese results indicated that the speci c inhibition of PEG10 expression using siRNA PEG10 enhanced the e ect of 5-FU on apoptosis.
To further explore whether overexpression of PEG10 promotes apoptosis resistance, the PEG10 expression plasmid, pcDNA3.0/PEG10, was constructed. HEK293T cells were transfected with pcDNA3.0/PEG10 or pcDNA3.0 at the same dose of 100 ng. Following 24 h of transfection, 5-FU was added to the culture medium, at a nal dosage of 40 μg/ml, to induce apoptosis. e apoptosis rate of HEK293T cells was detected 72 h a er transfection. e apoptosis rate of the 5-FU g roup wa s 15.14%. e ap optosis rates of the pcDNA3.0/PEG10 and pcDNA3.0 groups were both less than 8%. Vector transfection alone did not a ect the growth of HEK293T cells, whereas pcDNA3.0/PEG10 and pcDNA3.0 worked in a complimentary manner with 5-FU; the apoptosis rates were 7.84% and 15.23%, respectively (Fig 2) . HEK293T cells overexpressing PEG10 exhibited a greater viability 48 h a er treatment with 5-FU.
ese results indicated that speci c inhibition of PEG10 expression could increase the apoptosis rate of Raji cells induced by 5-FU. In contrast, overexpression of PEG10 would promote apoptosis resistance in Raji cells. is conclusion was consistent with our previous ndings that PEG10 plays a role in apoptosis in B-ALL cells [11] .
PEG10 promotes cell proliferation
To determine if the proliferation characteristics changed a er transfecting with siRNAPEG10 in Raji cell, cell viability was evaluated by CCK-8. Raji cells were transfected with siR-NAPEG10L (10 nM) and siRNAPEG10H (40 nM), respectively, and a control group was also transfected with unspeci c siRNA. A er the cells were incubated with di erent concentrations of siRNAPEG10 for 48 h, the proliferation of PEG10-silencing cells was lower than control cells (Plow<0.05, Phigh<0.05) (Fig. 3) . is demonstrates that downregulation of PEG10 expression, with both low (10 nM) and high (40 nM) concentrations of siRNA, signi cantly reduced the proliferation rate of Raji cells compared with the control. Prolifera-tion rate was more e ectively suppressed in cells transfected with the high concentration of siRNA compared with the low concentration (P<0.05). Our ndings indicated that a high concentration of siRNA was more e cient in abolishing PEG10 expression in Raji cells (Fig 5) and that the expression level of PEG10 was closely related to the proliferation of Raji cells in a dose-dependent manner.
PEG10 enhances cell adherence ability
We next examined the e ect of PEG10 on cell adhesion. e results indicated that downregulation of PEG10 expression of with both low (10 nM) and high (40 nM) concentrations of siRNA signi cantly reduced the adherence capability of Raji cells compared to the control (Plow<0.05, Phigh<0.05, Fig 3) . PEG10 a ected the adherence capability in a dose-dependent manner.
PEG10 is closely related to the expression level of MMP-2 and MMP-9
Among the proteinases capable of degrading the ECM, the matrix metalloproteinases (MMP-2 and MMP-9) appear to be particularly important [17, 18] . To explore the e ect of PEG10 on the invasion and migration capabilities of Raji cells, the mRNA and protein expression levels of these proteinases in PEG10-suppressed Raji cells were analysed. e results of realtime RT-PCR and Western blot analysis indicated that the expression levels of MMP-2 and MMP-9 were inhibited 48 hours a er abolishing the expression of PEG10. As the concentration of siRNAPEG10 increased, PEG10 expression was effectively suppressed, and both the MMP-2 and MMP-9 mRNA and protein expression levels gradually declined (Fig  4) , in a manner similar to the results of the adherence assay that we presented. ese results indicate that the expression level of PEG10 is closely related to the expression level of MMP-2 and MMP-9.
PEG10 promotes the migration and in asion abilities
Matrigel invasion assays were performed to further assess the e ect of PEG10 on the invasion potential of Raji cells (Fig 5) . In the control group, the Raji cells were transfected with nonspeci c siRNA.
e cells in the control group migrated through the Matrigel freely. When Raji cells were transfected with siRNAPEG10, the migration ability was signi cantly reduced (P<0.05). uantitative analysis demonstrated that the number of Raji cells migrating through the Matrigel was less in the group in which cells were transfected with high concentrations of siRNAPEG10 compared with low concentrations of siRNAPEG10 (P<0.05). is nding provided strong evidence that, with downregulation of PEG10 expression, the migration and invasion abilities of Raji cells were signi cantly inhibited compared with controls, and that this downregulation occurs ese results indicate that PEG10 is critical for the migration and invasion capabilities of Raji cells.
Discussion
BL is an aggressive B-cell neoplasm and is one of the most common lymphomas, especially in childhood. Although polychemotherapy regiments have improved clinical outcomes and changed the prognoses for BL patients, the high invasion and recurrence are still the most di cult aspects of the treatment.
PEG10 is identi ed as a maternally-imprinted and paternally expressed gene located at human chromosome 7q21 that functions as a transcriptional factor [3, 7] . Our previous reports have demonstrated that B-ALL CCL19/CCR7 and CXCL13/CXCR5 together upregulate PEG10 expression, and result in the enhancement of the apoptotic resistance of B-ALL CD23+CD5+B cells [11] . In this study, the role of PEG10 in lymphoma cell proliferation, apoptosis resistence, adhesion, migration and invasion was investigated.
e inhibition of PEG10 expression enhanced the apoptosis induced by 5-FU in Raji cells, whereas overexpression of PEG10 promoted the resistance to apoptosis induced by 5-FU.
ese results were consistent with our previous ndings that upregulation of PEG10 expression enhances the apoptotic resistance of leukemic cells [11] . Our ndings also suggest that PEG10 functions as an important oncogene in the progression of lymphoma by inhibiting cell growth and increasing tolerance to apoptosis. is has already been demonstrated in HCC cell lines and may involve interaction with SIAH1 [6] .
Tumor cell invasion is a multistep phenomenon, in which extensive degradation of the matrix is the most critical step [20] . MMP-2 and MMP-9 are enzymes that degrade collagen type IV, the principal component of basement membranes, and are thought to be associated with the transmigration and degradation of the ECM structures of tissue and blood vessels [14, 21] . In this study, the expression levels of MMP-2 and MMP-9 were signi cantly inhibited, both at the mRNA and protein levels, through the downregulation of PEG10 expression. Since MMP-2 and MMP-9 are closely related to the invasion phenotype of cancer cells, our results further suggest that PEG10 expression levels a ect the invasion capabilities of cancer cells is deduction was demonstrated in the Matrigel invasion assays: the invasion capabilities of Raji cells were signi cantly reduced as PEG10 expression was suppressed. In addition, the cell adhesion abilities of Raji cells were also decreased upon downregulation of PEG10 expression.
In this study PEG10 was found to enhance the adhesion, migration and invasion capabilities of Raji cells. e excessive egress of cells from the marrow into peripheral blood and subsequent in ltration into various tissues is crucial for the malignant progression [22] . In order for these cells to invade and migrate to new sites in the body, they must rst attain the ability to catalytically modify the ECM and the basement membranes and PEG10 may promote the progression of these crucial steps. us, PEG10 activity is important for the prognosis of BL: by downregulating PEG10 expression, the malignant progression of BL could potentially be suppressed.
In summary, our study demonstrates the importance of PEG10 expression in BL cell apoptosis resistance, proliferation, adhesion, migration and invasion. PEG10 is potentially useful as a prognostic marker for the aggressiveness of BL. Our results add to the understanding of the role of PEG10, and provide a new molecular target for blocking BL invasion. Further investigation into PEG10 expression in additional lymphoma cell lines and clinical samples is warranted.
